UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN
PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2026
Commission File
Number: 001-41982
Auna S.A.
(Exact name of registrant as specified in its
charter)
6, rue Jean Monnet
L-2180 Luxembourg
Grand Duchy of Luxembourg
+51 1-205-3500
(Address of principal executive office)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F:
TABLE OF CONTENTS
| EXHIBIT |
|
| 99.1 |
Auna Announces Results of Annual General Meeting and Board Composition Update |
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
Auna S.A. |
| |
|
| |
|
| |
By: |
/s/ Gisele Remy |
| |
|
Name: |
Gisele Remy |
| |
|
Title: |
Chief Financial Officer |
Date: July 7, 2026
Exhibit 99.1
Auna
Announces Results of Annual General Meeting and Board Composition Update
Luxembourg–
July 7, 2026 - Auna S.A. (“Auna” or the “Company”) (NYSE: AUNA), a Latin American healthcare company with
operations in Mexico, Peru and Colombia, announced today the results of its annual general meeting of shareholders held on June 30, 2026
(the “Annual General Meeting”). The Company’s shareholders approved and adopted all of the matters submitted to them,
as described below.
| 1. | Convening
formalities. The shareholders confirmed that the Annual General Meeting had been duly convened
and validly constituted. |
| 2. | Confirmation
of share awards to independent directors. The shareholders confirmed the share awards granted
to the independent directors, as approved by the board of directors of the Company (the “Board”),
with the directors concerned having abstained under Article 441-7 of the Luxembourg law of
August 10, 1915 on commercial companies, as amended. |
| 3. | Approval
of the 2025 reports, accounts and allocation of the result. The shareholders approved the
Board’s management reports and the reports of the statutory auditor of the Company
(the “Statutory Auditor”) and the contractual auditor for the financial year
ended December 31, 2025 (the “2025 Financial Year”); approved the Company’s
separate annual accounts and its consolidated financial statements prepared for Luxembourg
regulatory purposes and for the information of investors; and resolved on the allocation
of the result for the 2025 Financial Year as proposed by the Board. |
| 4. | Discharge
to the directors. The shareholders granted discharge to the directors for the performance
of their mandate for the 2025 Financial Year. |
| 5. | Discharge
and reappointment of the Statutory Auditor. The shareholders granted discharge to the Statutory
Auditor for the 2025 Financial Year and reappointed it for the financial year ending December
31, 2026, until the annual general meeting to be held in 2027. |
| 6. | Ratification
of remuneration and compensation. The shareholders ratified the directors’ remuneration
and the compensation granted to certain directors by the Compensation and Talent Committee
and approved by the Board for the 2025 Financial Year. |
| 7. | Miscellaneous.
No other business was transacted at the Annual General Meeting. |
Board
Composition Update
Separately,
the Board has determined that a seven-member Board is appropriate for Auna at this time. Accordingly, Jorge Basadre and Guadalupe Phillips
have stepped down from the Board, effective July 6, 2026. The Board does not intend, at this time, to fill the resulting vacancies.
Following
these changes, the Board continues to have a majority of independent directors.
The
Board and management team thank Jorge and Guadalupe for their service and contributions to Auna during an important period for the Company
and wish them continued success in their future endeavors.
About
Auna
Auna
is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru, and Colombia. It prioritizes prevention
and focuses on complex diseases that represent the highest healthcare spending. Its mission is to transform healthcare by delivering
access to a highly integrated offering of services in low-penetration markets across Spanish-speaking Latin America. Founded in 1989,
Auna has built one of the region’s largest modern healthcare platforms, consisting of a horizontally integrated network of medical
care centers and a vertically integrated portfolio of oncology and general health plans. As of March 31, 2026, Auna’s network included
31 healthcare facilities—hospitals, ambulatory centers, and prevention and wellness centers—with a total of 2,337 beds and
1.4 million health plan members.
For
more information visit www.aunainvestors.com
Investor
Relations Contact contact@aunainvestors.com